Scientists track inflammation to predict cancer drug side effects
NCT ID NCT05707286
Summary
This study aims to understand when inflammation peaks in the body after starting a common type of cancer immunotherapy. Researchers measured markers in the blood of 98 adults with various cancers to see if these markers could predict side effects or interactions with other medications. The goal is to gather information to help doctors better manage treatment for future patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MELANOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Indiana University Melvin and Bren Simon Comprehensive Cancer Center
Indianapolis, Indiana, 46202, United States
Conditions
Explore the condition pages connected to this study.